Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC16A3 | O15427 | 13/20 | 1.00 |
| ▸ | BCL2 | P10415 | 1/20 | 0.54 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.54 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.54 |
| ▸ | BCL2A1 | Q16548 | 1/20 | 0.54 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.52 |
| ▸ | NCOR2 | Q9Y618 | 2/20 | 0.52 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.52 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.51 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3562788 | 0.93 | SLC16A3 (0.88) | SLC16A3BCL2BCL2L1MCL1BCL2A1 | |
| SCHEMBL3556736 | 0.89 | SLC16A3 (1.00) | SLC16A3BCL2BCL2L1MCL1BCL2A1 | |
| SCHEMBL3553847 | 0.87 | SLC16A3 (0.76) | SLC16A3HDAC3NCOR2HDAC1HDAC2 | |
| SCHEMBL3563084 | 0.86 | SLC16A3 (0.75) | SLC16A3BCL2BCL2L1MCL1BCL2A1 | |
| SCHEMBL3563444 | 0.85 | SLC16A3 (0.74) | SLC16A3BCL2BCL2L1MCL1BCL2A1 | |
| SCHEMBL3557994 | 0.84 | SLC16A3 (0.72) | SLC16A3HDAC3NCOR2HDAC1HDAC2 | |
| SCHEMBL3555286 | 0.84 | SLC16A3 (0.72) | SLC16A3HDAC3NCOR2HDAC1HDAC2 | |
| SCHEMBL3567080 | 0.84 | SLC16A3 (0.72) | SLC16A3MCL1BCL2A1HDAC3NCOR2 | |
| SCHEMBL3564276 | 0.84 | SLC16A3 (0.72) | SLC16A3HDAC3NCOR2HDAC1HDAC2 | |
| SCHEMBL3556734 | 0.84 | SLC16A3 (0.72) | SLC16A3HDAC3NCOR2HDAC1HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7816397-B2 | Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes | MERCK PATENT GMBH (DE) | 2010-10-19 | — | — | US | claimed |
| US-20080045483-A1 | Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes | MERCK PATENT GMBH (DE) | 2008-02-21 | — | — | US | claimed |
| US-7816397-B2 | Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes | MERCK PATENT GMBH (DE) | 2010-10-19 | — | — | US | disclosed |
| US-20080045483-A1 | Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes | MERCK PATENT GMBH (DE) | 2008-02-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080045483-A1 | Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes | SLC5A1, ALDH7A1, ASS1 | SLC16A3 425/4885BCL2 1996/4885BCL2L1 1644/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.